Skip to main content

Table 1 Comparison of patient clinical characteristics

From: Clinicopathological analysis and prognostic treatment study of angiosarcoma of the breast: a SEER population-based analysis

 

Primary angiosarcoma, n (%)

Secondary angiosarcoma, n (%)

p value

Total

100

147

 

Median age

50–54

70–74

 

  < 65

64 (64.0)

38 (25.9)

 

  ≥ 65

36 (36.0)

109 (74.1)

p < 0.001

Race

 White

79 (79.0)

133 (90.5)

 

 Non-whitea

21 (21.0)

14 (9.5)

p = 0.011

Site

 Centralb

4 (4.0)

13 (8.9)

 

 Inner quandrant

13 (13.0)

14 (9.5)

 

 Outer quandrant

16 (16.0)

24 (16.3)

 

 Overlap

31 (31.0)

26 (17.7)

 

 NOSc

36 (36.0)

70 (47.6)

p = 0.058

Grade

 G1

21 (21.0)

10 (6.8)

 

 G2

28 (28.0)

19 (12.9)

 

 G3

27 (27.0)

47 (32.0)

 

 Gxd

24 (24.0)

71 (48.3)

p < 0.001

Tumour size

  < 5 cm

49 (49.0)

79 (53.8)

 

 5-10 cm

33 (33.0)

54 (36.7)

 

  > 10 cm

18 (18.0)

14 (9.5)

p = 0.15

Tumour spread

 Local

74 (74.0)

67 (45.6)

 

 Regional

18 (18.0)

74 (50.3)

 

 Distant

8 (8.0)

6 (4.1)

p < 0.001

Tumour extension

 Confined

79 (79.0)

68 (46.3)

 

 Local infiltration

10 (10.0)

41 (27.9)

 

 Deep

11 (11.0)

38 (25.8)

p < 0.001

Total number

 1

75 (75.0)

0 (0)

 

 2

21 (21.0)

96 (65.3)

 

  ≥ 3

4 (4.0)

51 (34.7)

p < 0.001

Chemotherapy

 Yes

37 (37.0)

32 (21.8)

 

 No

63 (63.0)

115 (78.2)

p = 0.09

Radiation

 Yes

31 (31.0)

25 (17.0)

 

 No

69 (69.0)

122 (83.0)

p = 0.01

Surgery

 Yes

96 (96.0)

146 (99.3)

 

 No

4 (4.0)

1 (0.7)

p < 0.001

  1. aWe recoded detailed race information into four major categories, the non-White population includes Black, American Indian/Alaska Native, and Asian Pacific Islander
  2. bClassify tumor at the nipple in the central group of the breast
  3. cEntire breast: 3/4 or more of breast involved with tumor
  4. dUndifferentiated, anaplastic, and grade IV